Celluma is a light energy device approved by the FDA for the treatment of skin and musculoskeletal conditions. It is a therapy that involves the application of light energy to the skin for aesthetic reasons. Most commonly used light is in the frequency of red to blue.
The mechanism of action is similar to that of photosynthesis in plants as it promotes photo biochemical reactions. The LED light reacts with cytochromes, raising their energy level and thus, stimulating tissue regeneration.
The advantages of celluma light therapy includes: enhancement of cellular metabolism, acceleration of repair following skin damage by the stimulation of collagen synthesis, improving skin smoothness, and help restore the natural cellular activity. It also reduces the appearance of wrinkles, acne, and hyperpigmentation.
The treatment is widely accepted as it is painless, non-invasive, and has proven to work on all skin types. It is also devoid of adverse effects associated with other forms of skin treatment such as dermabrasions, lasers, etc.
The number of treatments required depends on the skin condition being treated and the level of improvement desired. However for optimal result the recommended treatment is a 30minutes session twice per week for 4-6 weeks with occasional maintenance therapy.
What Are the Contraindications To Celluma Light Treatment?
There are various conditions when celluma light therapy should be avoided or used with care. These conditions are: pregnancy, use of medications that cause photosensitivity, epilepsy, patients with cancers, patients on corticosteroid, etc. For these conditions you should contact your physician before embarking on the treatment.
The celluma light therapy has been said to have teratogenic effects on the developing fetus. Thus it should be avoided especially around the time of conception and during the first trimester of pregnancy. In the later part of pregnancy, a physician’s consent must be sought before instituting the therapy.
Patient must wait for at least five days after the use of cosmetic fillers before using celluma.
Medications such as chlorpromazine cause photosensitivity and should be avoided before celluma light treatment. Other medications that require a physician’s approval before celluma therapy are: amiodarone, methotrexate, tretinoin, tetracycline, griseofulvin, etc.
Those with epilepsy should also consult their physicians before undergoing celluma light therapy. Although light therapy has been found to be beneficial in epileptic patients especially in reducing depression and anxiety in them, however, it can lower the seizure threshold and makes them to experience more attacks.
Though FDA approved and found to be effective in the management of various skin and musculoskeletal diseases, celluma light therapy should be administered with care in those with the above listed conditions and preferably a physician’s approval should be sought before the commencement of the treatment.